Cleveland Clinic Cancer Advances
Monoclonal Gammopathy of Undetermined Significance (MGUS)
May 18, 2023
Cleveland Clinic Taussig Cancer Institute
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Cleveland Clinic Cancer Advances
More Info
Share
Cleveland Clinic Cancer Advances
Monoclonal Gammopathy of Undetermined Significance (MGUS)
May 18, 2023
Cleveland Clinic Taussig Cancer Institute
Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.
Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.